Centessa Pharmaceuticals PLC ADR
Price & Volume
Stats
See more52W Range | $9.60-$24.57 |
Market Cap | $3B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $15M |
Diluted EPS | -$1.83 |
News
See moreYahoo Finance • 26 days ago
LifeSci Capital Reaffirms Buy Rating on Centessa Pharmaceuticals (CNTA) with a $39 PT, Anticipates Key Orexin Pipeline Data
Yahoo Finance • last month
Centessa rated Outperform at Oppenheimer on ORX750 potential
Yahoo Finance • 2 months ago
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025
Yahoo Finance • 2 months ago
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
About
CEO | Dr. Saurabh Saha M.D., Ph.D. |
CFO | Mr. John J. Crowley CPA |
Address | 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 98 |
